Bristol Myers Squibb

Legal Entities

• Bristol-Myers Squibb Company

Overview

Bristol Myers Squibb Company formed from the 1989 merger of Bristol-Myers Company and Squibb Corporation, with headquarters in New York. It focuses on oncology, immunology, cardiovascular, and hematology therapies.

UK trademark portfolios map to biologic brand names and companion diagnostic collaborations. Post-merger groups frequently rationalise legacy marks while expanding oncology naming systems designed for global pronounceability and regulatory acceptance.

Visit Bristol Myers Squibb website →